TEVA240830C17500
- 1.20
- +0.07+6.19%
Teva Pharmaceutical Industries Newsroom
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?
SAS Taps Former Novo Nordisk Executive as Chair in Board Reshuffle
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23
Is it Harris' turn to dominate the market? Wall Street is adjusting its bets.
① Harris continued to make great progress in the polls, which directly led to Wall Street ignoring the "Trump trade"; ② Specific industries and stocks in the US stock market have been affected, but overall they are not as strong as the "Trump trade"; ③ Analysts point out that the results of the "Hart" competition are not absolute, and it is not yet time to lock in positions.
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Cigna PBM Express Scripts to Remove Humira From Many Formularies
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating
Express News | Teva : BofA Global Research Raises Price Objective to $22 From $21
Generic Weight-Loss Drugs Won't Come for Years -- Barrons.com
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
Medincell: Participation Terms in the Combined General Meeting
Glenview Capital's Q2 Moves Include Selling Broadcom After Just One Quarter, Exiting Meta
Teva Pharmaceutical Industries Options Spot-On: On August 14th, 82,334 Contracts Were Traded, With 730.61K Open Interest
Teva Pharmaceutical Hits a New 52-week High
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Teva Pharmaceutical Industries Insider Sold Shares Worth $782,972, According to a Recent SEC Filing
Harris Leads Trump in Polls. Which Stocks Could Benefit from Her Policies?
Express News | Teva : HSBC Raises Target Price to $23 From $20
Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags